Bloomberg Technology

Ginkgo Bioworks Is Expanding Covid Testing Business

Aug.24 — Ginkgo Bioworks CEO Jason Kelly speaks with Bloomberg’s Emily Chang to discuss the synthetic biology firm’s expansion of covid testing and how their unique foundry model is developing future breakthroughs.

Published

3 years ago

on

Aug.24 — Ginkgo Bioworks CEO Jason Kelly speaks with Bloomberg’s Emily Chang to discuss the synthetic biology firm’s expansion of covid testing and how their unique foundry model is developing future breakthroughs.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version